Wnt/β-catenin signaling components and mechanisms in bone formation, homeostasis, and disease.

Hu L, Chen W, Qian A, Li YP. · 2024

Read Wnt/β-catenin signaling components and mechanisms in bone formation, homeostasis, and disease. by Hu L, Chen W, Qian A, Li YP. (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc11237130.txt.

Introduction

Hu, Chen, Qian, and Li update the picture of one signal pathway in bone in this 2024 review. Wnt proteins are secreted, fat-tagged signals that bind receptors on cell surfaces. Their canonical path, run through beta-catenin, controls many processes in development and adult life. Faulty Wnt signalling underlies a wide range of human diseases.

The review sums up the pathway's proteins, receptors, activators, and inhibitors in bone. It details how the path crosstalks with other pathways. Mouse models carrying tweaks to Wnt components are catalogued as evidence. Bone formation, upkeep, and related diseases form the core. Treatment strategies are sorted by where they strike: outside the cell, in the cell body, or in the nucleus. The authors close by judging how well the field grasps this control system.

Catalog record

CREATORHu L, Chen W, Qian A, Li YP.
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE223 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11237130

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Wnt/β-catenin signaling components and mechanisms in bone formation, homeostasis, and disease By Lifang Hu, Wei Chen, Airong Qian, Yi-Ping Li Published in: Bone Research DOI: 10.1038/s41413-024-00342-8 ABSTRACT Wnts are secreted, lipid-modified proteins that bind to different receptors on the cell surface to activate canonical or non-canonical Wnt signaling pathways, which control various biological processes throughout embryonic development and adult life. Aberrant Wnt signaling pathway underlies a wide range of human disease pathogeneses. In this review, we provide an update of Wnt/β-catenin signaling components and mechanisms in bone formation, homeostasis, and diseases. The Wnt proteins, receptors, activators, inhibitors, and the crosstalk of Wnt signaling pathways with other signaling pathways are summarized and discussed. We mainly review Wnt signaling functions in bone formation, homeostasis, and related diseases, and summarize mouse models carrying genetic modifications of Wnt signaling components. Moreover, the therapeutic strategies for treating bone diseases by targeting Wnt signaling, including the extracellular molecules, cytosol components, and nuclear components of Wnt signaling are reviewed. In summary, this paper reviews our current understanding of the mechanisms by which Wnt signaling regulates bone formation, homeostasis, and the efforts targeting Wnt signaling for treating bone diseases. Finally, the paper evaluates the important questions in Wnt signaling to be further explored based on the progress of new biological analytical technologies. INTRODUCTION Wnt signaling, an evolutionarily conserved signaling pathway from nematodes to mammals, plays key roles in regulating multiple biological processes, including embryonic development, organogenesis, tissue homeostasis in adults, and numerous diseases.1,2 The term “Wnt” is the combination of the terms “wingless” and “int”.3 Int-1, which was later renamed Wnt1, is the first Wnt gene discovered in mouse breast tumors induced by mouse mammary tumor virus in 1982.4 The wingless gene, which controls segment pattern during the development of Drosophila larva,5 was identified as the homolog of Wnt1 (int-1) in 1987.6 Later, researchers demonstrated the Wnt signal transduction in Drosophila by delineating the components of the signaling, including zeste-white 3 (the homolog of mammalian glycogen synthase kinase 3 (GSK3)), disheveled (Dvl), and armadillo (the homolog of vertebrate β-catenin).7–9 Further, injection of Xenopus eggs with mouse Wnt1 RNA caused duplication of the embryonic axis, suggesting a critical role of Wnt signaling in vertebrate development.10 These foundational studies reveal the importance of Wnt signaling in development. Since these pioneering discoveries, there is an explosion of research on the Wnt signaling pathway, ranging from signal transduction and complex regulation to its role in normal development and diseases. There are 19 known Wnt proteins that either function through the canonical Wnt signaling pathway or the non-canonical Wnt signaling pathway. The best-studied Wnt signaling pathway is the canonical Wnt signaling pathway, which is also referred to as the Wnt/β-catenin signaling pathway for its dependency on β-catenin transcriptional function. Otherwise, the non-canonical Wnt signaling pathway is a β-catenin independent pathway. There are two well-known non-canonical Wnt signaling pathways: the Wnt/planar cell polarity (PCP) pathway and the Wnt/Ca2+ pathway. Both canonical and non-canonical Wnt signaling pathways play crucial roles in normal tissue development and homeostasis.11–13 Moreover, the Wnt signaling pathway plays key roles in the pathogenesis of human diseases. In the early 1990s, the Kinzler and Nishisho groups independently found the adenomatous polyposis coli (APC) gene in familial adenomatous polyposis, a hereditary cancer syndrome, which was the first connection of the Wnt signaling pathway to human disease.14,15 Later, the APC protein was found to interact with β-catenin16,17 and APC deficiency resulted in constitutively active β-catenin/TCF (T-cell factor) signaling in colon carcinoma cells.18 These findings demonstrated the close link between Wnt signaling and human disease. After decades of research, evidence show that Wnt signaling pathways is involved in many human diseases, including numerous tissue diseases, metabolic diseases, and cancers.2,19–21 As an evolutionarily conserved complex signaling pathway, Wnt signaling is involved in multiple key events during embryo development and adult tissue homeostasis. Wnt signaling shows versatility not only in the signaling components but also in its physiological and pathological functions. This review summarizes the current knowledge of Wnt signaling pathways and reviews the advances of Wnt signaling pathways in bone formation, homeostasis, and disease. Furthermore, the therapeutic treatment of bone disease by targeting Wnt signaling is also discussed. Overall, this review will provide researchers with a comprehensive understanding of Wnts, the role of Wnt signaling pathways in bone homeostasis and disease, and therapeutics that target Wnt signaling and will serve as a reference for future studies. WNT PROTEINS, WNT RECEPTORS, AND WNT SIGNALING PATHWAY Wnt proteins (Wnts) The Wnt proteins (Wnts) act as intercellular signals and regulate a wide range of cellular behavior including cell fate specification, cell proliferation, survival, migration, polarity, and differentiation.19 Wnt proteins are conserved in all metazoan animals along with multiple associated genes. There are 19 in mammals, 16 in Xenopus, 11 in chicks, 12 in zebrafish, 7 in Drosophila, and 5 in C. elegans (http://www.stanford.edu/rnusse/wntwindow.html). Wnts encoded by Wnt genes are ~40 kD-secreted glycoproteins that are structurally related, containing 23 or 24 cysteine residues.22 The demonstration of Wnts as a lipid-modified protein was confirmed through the first successful purification of Wnt3a.23 The lipid modification involves the attachment of a palmitoleic acid (a mono-unsaturated fatty acid) to a highly conserved serine residue.24 The palmitoylation of Wnt is required for its binding to the Frizzled (Fzd) receptor, initiating signal transduction, and the glycosylation of Wnt that is necessary for its eventual secretion.25 Wnts were historically categorized as either canonical or noncanonical Wnts.26 However, the distinction is questionable because some Wnts can stimulate both canonical and noncanonical Wnt signaling pathways and typically noncanonical Wnts can activate canonical Wnt signaling.27–30 Wnt receptors and co-receptors Wnt signal transduction involves the binding of Wnts to cell-surface Wnt receptors and co-receptors, which primarily contain members of the Fzd family31 and the low-density lipoprotein receptor-related protein (LRP) family.32 Further, the receptor tyrosine kinase-like orphan receptor-1 (ROR1), ROR2,33 an atypical receptor tyrosine kinase (Ryk),34,35 protein tyrosine kinase 7 (PTK7),36 muscle-specific kinase (MuSK),37 and other molecules were also demonstrated as Wnt co-receptors. Frizzled (Fzd) proteins Fzd proteins are widespread high-affinity Wnt receptors. From the first Wnt receptor identified,38 the Fzd family now contains 10 members in humans, Fzd1 to Fzd10.39 They are seven-transmembrane receptors containing a large extracellular N-terminal cysteine-rich domain (CRD), which is conserved among the receptor family and mediates high-affinity binding to Wnts.31,40–42 Fzds transmit signaling through both canonical and non-canonical Wnt signaling pathways by cooperating with other co-receptors (Fig. 1). In the Wnt/β-catenin signaling pathway, Wnt–Fzd form a ternary complex with low-density lipoprotein receptor-related protein 5/6 (LRP5/6), whereas, in Wnt/PCP signaling pathway, Wnt–Fzd interact with ROR32,33,43 (see below: Wnt signaling pathways, Fig. 1).Fig. 1Schematic representation of canonical and non-canonical Wnt signaling pathway. a The canonical Wnt signaling pathway in inactive and active status. Without Wnt binding, β-catenin is sequestered by a destruction complex composed of GSK3β, Axin, APC, and CK1, which leads to the phosphorylation of β-catenin at serine/threonine residues. Phosphorylated β-catenin is then undergoing the proteosomal degradation mediated by polyubiquitination. The Wnt signaling is in inactive status. When Wnt binds to its receptor complex, including the seven-transmembrane receptor Fzd and the co-receptor LRP5 or LRP6, Wnt/β-catenin is initiated. This binding mobilizes GSK3β and CK1 to the cell membrane, where they phosphorylate serines on Lrp5/6, promoting the formation

Read the complete text